Loading clinical trials...
Loading clinical trials...
A Randomised, Multicenter, Open-Label, Parallel Group Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Unfractionated Heparin as Anticoagulant Treatment in Patients Undergoing Haemodialysis Via an Arteriovenous Graft
Conditions
Interventions
PEG-hirudin
Locations
1
United States
Pennsylvania Hospital - Franklin Dialysis Center
Philadelphia, Pennsylvania, United States
Start Date
November 1, 2003
Completion Date
January 1, 2006
Last Updated
October 5, 2007
NCT05418816
NCT00804453
NCT05105009
NCT01450670
NCT03076528
NCT03142529
Lead Sponsor
Speedel Pharma Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions